Park End Street
Oxford, Oxfordshire OX1 1HH
UK
OBR would like to invite you to our next event in Oxford on Wednesday 16th July at Saïd Business School, University of Oxford.
Since the completion of the Human Genome Project, the birth of next-generation sequencing (NGS) has brought exponentially faster and cheaper nucleic acid sequencing methods to scientists, and takes us tantalisingly closer to an era of personalised medicine.
The scope for clinical applications of NGS seems boundless, and this event will provide deeper insights into how academia, established industry and budding start-ups can benefit from the latest advances in the field.
Panellists/Speakers
Gordon Sanghera – CEO of Oxford Nanopore
Stephen Little – CEO of Premaitha Health &
VP of Personalised Healthcare at QIAGEN
Neil Ward – UK District Marketing Manager at Illumina
Anna Schuh – Head of the Molecular Diagnostics Centre at University of Oxford
Join our expert panel from academia and industry speakers to discuss the most crucial challenges in next generation sequencing and its potential applications.
Informal networking drinks will follow the main event.